Holen Sie sich die Stockscreener-App
45.54
6.64%
-3.24
Handel nachbörslich:
45.54
Schlusskurs vom Vortag:
$48.78
Offen:
$48.77
24-Stunden-Volumen:
657.75K
Relative Volume:
1.35
Marktkapitalisierung:
$1.44B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
38.27
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
+0.02%
1M Leistung:
-3.17%
6M Leistung:
+40.73%
1J Leistung:
+36.59%
1-Tages-Spanne:
$45.01
$49.04
1-Wochen-Bereich:
$44.51
$49.17
52-Wochen-Spanne:
$23.23
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
45.54 | 1.54B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
How Good Is Collegium Pharmaceutical, Inc. (NASDAQ:COLL), When It Comes To ROE? - 富途牛牛
What 6 Analyst Ratings Have To Say About Collegium Pharmaceutical - Benzinga
Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthJuly 2025 Retail & Daily Growth Stock Tips - ulpravda.ru
How Collegium’s New $980 Million Credit Facility Could Reshape Collegium Pharmaceutical (COLL) Investors’ Risk Lens - Sahm
Is Collegium Pharmaceutical Inc. stock trading at a premium valuationQuarterly Trade Summary & Consistent Return Strategy Ideas - ulpravda.ru
How Collegium Pharmaceutical Inc. (354) stock reacts to monetary easingJuly 2025 Setups & Advanced Technical Signal Analysis - ulpravda.ru
Collegium Pharmaceutical, Inc. Announces 2026 Financial Guidance - TradingView — Track All Markets
Collegium Provides 2026 Financial Guidance and Business Update - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat
Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail
Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily
Collegium Pharmaceutical Closes New $980 Million Credit Facility - TipRanks
Collegium Pharmaceutical Closes $980 Million Syndicated Credit Facility - marketscreener.com
Collegium Pharmaceutical Signs Credit Agreement With Truist Bank - TradingView — Track All Markets
Collegium Pharmaceutical, Inc. Announces the Closing of $980 Million Syndicated Credit Facility - MarketScreener
Exchange Traded Concepts LLC Reduces Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
2 Reasons to Avoid COLL and 1 Stock to Buy Instead - Barchart.com
Collegium Pharmaceutical stock hits all-time high at 49.92 USD By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighStill a Buy? - MarketBeat
Collegium Pharmaceutical stock hits all-time high at 49.92 USD - Investing.com India
Is Collegium Pharmaceutical Inc a good long term investmentMarket Rumors and News & High Yield Trading Plans - earlytimes.in
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - sharewise.com
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Assenagon Asset Management S.A. Purchases 92,898 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesInsider Buying & Advanced Technical Analysis Signals - Улправда
How rising interest rates impact Collegium Pharmaceutical Inc. stockWeekly Investment Report & Safe Capital Investment Plans - Улправда
Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? - Yahoo Finance
Can Collegium Pharmaceutical Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - Улправда
Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily
Published on: 2025-12-19 17:44:17 - DonanımHaber
Is Collegium Pharmaceutical Inc. stock positioned for digital transformationJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
3 Unpopular Stocks We Find Risky - Finviz
Will Collegium Pharmaceutical Inc. stock deliver strong dividend growthMarket Volume Report & Comprehensive Market Scan Reports - DonanımHaber
Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingJuly 2025 Sentiment & High Conviction Investment Ideas - DonanımHaber
How Collegium Pharmaceutical Inc. stock performs in weak economy - Улправда
Trade Recap: Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spending2025 Support & Resistance & Reliable Intraday Trade Plans - DonanımHaber
Collegium Pharmaceutical Earnings Notes - Trefis
Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketJuly 2025 Movers & Long Hold Capital Preservation Tips - Улправда
Best Value Stocks to Buy for Dec. 18 - sharewise.com
Strong Q3 Beat and Guidance Upside Might Change The Case For Investing In Collegium Pharmaceutical (COLL) - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - 富途牛牛
Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance - simplywall.st
Collegium Pharma spikes after 2025 outlook - MSN
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):